Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 24,681 - 24,700 results of 52,235 for search '(( a ((linear decrease) OR (mean decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 0.77s Refine Results
  1. 24681

    Data_Sheet_1_Probiotics, prebiotics, and synbiotics for patients with autism spectrum disorder: a meta-analysis and umbrella review.docx by Fakher Rahim (582745)

    Published 2023
    “…Regarding the enhancement of autism-related behavioral symptoms, there wasn’t a statistically significant difference between the intervention groups (combined standardized mean difference = −0.07, 95% confidence interval: −0.39 to 0.24, Z = 0.46, p = 0.65). …”
  2. 24682

    Image5_Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods.PNG by Zi-Qian Liang (12650434)

    Published 2022
    “…Finally, DUSP1 may have a targeting relation with paclitaxel and participate in MAPK signaling pathways.…”
  3. 24683

    Table_2_Tractography in Type 2 Diabetes Mellitus With Subjective Memory Complaints: A Diffusion Tensor Imaging Study.docx by Jun Wang (5906)

    Published 2022
    “…Decreased axial diffusivity (AD) in the left arcuate was associated with HbA<sub>1c</sub> (r = −0.368, p = 0.049). …”
  4. 24684

    Table1_Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods.DOCX by Zi-Qian Liang (12650434)

    Published 2022
    “…Finally, DUSP1 may have a targeting relation with paclitaxel and participate in MAPK signaling pathways.…”
  5. 24685

    Video 2_Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot study.mp4 by Vladimir Gabai (38129)

    Published 2025
    “…Improvement in CBPI was observed after 2–4 weeks of treatment, whereas after 5–6 weeks of the treatment the parameters reached the plateau. After 10 weeks mean PSS score after the treatment decreased from 5.25 to 3.25, PIS score - from 7.0 to 3.27, and number of dogs with excellent and good QoL due to treatment increased from 1 to 12. …”
  6. 24686

    Data_Sheet_1_Immediate Ocular Changes After Light-Emitting Diode Displays Exposure—A Preliminary Study.pdf by Chia-Chen Lin (1800670)

    Published 2022
    “…The CVS-Q score significantly improved after short-term LED exposure (P < 0.001). A subgroup analysis of subjects with a baseline LLT of <60 nm or ≥60 nm determined that LLT significantly decreased in individuals with a baseline LLT of ≥60 nm (P = 0.016).…”
  7. 24687

    Table_1_Gross total resection and survival outcomes in elderly patients with spinal chordoma: a SEER-based analysis.docx by John Pham (4710034)

    Published 2024
    “…The frequency of receiving GTR also decreased as a function of age (16.4% [80-99 years] vs. 43.2% [20-39 years]; p<0.001), but the frequency of receiving radiotherapy was comparable across all age groups (48.3% [80-99 years] vs. 45.5% [20-39 years]; p=0.762).…”
  8. 24688

    Video 3_Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot study.mp4 by Vladimir Gabai (38129)

    Published 2025
    “…Improvement in CBPI was observed after 2–4 weeks of treatment, whereas after 5–6 weeks of the treatment the parameters reached the plateau. After 10 weeks mean PSS score after the treatment decreased from 5.25 to 3.25, PIS score - from 7.0 to 3.27, and number of dogs with excellent and good QoL due to treatment increased from 1 to 12. …”
  9. 24689

    Table_3_Tractography in Type 2 Diabetes Mellitus With Subjective Memory Complaints: A Diffusion Tensor Imaging Study.docx by Jun Wang (5906)

    Published 2022
    “…Decreased axial diffusivity (AD) in the left arcuate was associated with HbA<sub>1c</sub> (r = −0.368, p = 0.049). …”
  10. 24690

    Table2_Intravenous esketamine as an adjuvant for sedation/analgesia outside the operating room: a systematic review and meta-analysis.DOCX by Ziheng Kan (18964144)

    Published 2024
    “…The pooled results of adults showed that compared with drug regimens of the control group, intravenous esketamine combinations were significantly associated with decreased risk of oxygen desaturation (RR = 0.49, 95% CI = [0.34, 0.70]); hypotension (RR = 0.38, 95% CI = [0.31, 0.46]); bradycardia (RR = 0.23, 95% CI = [0.12, 0.43]); injection pain (RR = 0.37, 95% CI = [0.25, 0.53]); body movement (RR = 0.60, 95% CI = [0.41, 0.88]); and propofol consumption (SMD = −1.38, 95% CI = [−2.64, −0.11]), but an increased risk of psychiatric symptoms (RR = 3.10, 95% CI = [2.11, 4.54]) (RR = relative risk; CI = confidence intervals; SMD = standardized mean difference). …”
  11. 24691

    Presentation_1_Neuroprotective effect of remote ischemic preconditioning in patients undergoing cardiac surgery: A randomized controlled trial.pdf by Shouqiang Zhu (13718434)

    Published 2022
    “…Secondary endpoints included changes in Neuron-specific enolase (NSE), Mini-mental State Examination (MMSE), and Montreal Cognitive Assessment (MoCA) levels.</p>Results<p>A total of 120 patients [mean age, 48.7 years; 36 women (34.3%)] were randomized at three cardiac surgery centers in China. …”
  12. 24692

    Image1_Intravenous esketamine as an adjuvant for sedation/analgesia outside the operating room: a systematic review and meta-analysis.JPEG by Ziheng Kan (18964144)

    Published 2024
    “…The pooled results of adults showed that compared with drug regimens of the control group, intravenous esketamine combinations were significantly associated with decreased risk of oxygen desaturation (RR = 0.49, 95% CI = [0.34, 0.70]); hypotension (RR = 0.38, 95% CI = [0.31, 0.46]); bradycardia (RR = 0.23, 95% CI = [0.12, 0.43]); injection pain (RR = 0.37, 95% CI = [0.25, 0.53]); body movement (RR = 0.60, 95% CI = [0.41, 0.88]); and propofol consumption (SMD = −1.38, 95% CI = [−2.64, −0.11]), but an increased risk of psychiatric symptoms (RR = 3.10, 95% CI = [2.11, 4.54]) (RR = relative risk; CI = confidence intervals; SMD = standardized mean difference). …”
  13. 24693

    Image2_Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods.PNG by Zi-Qian Liang (12650434)

    Published 2022
    “…Finally, DUSP1 may have a targeting relation with paclitaxel and participate in MAPK signaling pathways.…”
  14. 24694

    Table_1_Social isolation and mental well-being among Korean older adults: a focus on living arrangements.docx by Geon Lee (6187724)

    Published 2024
    “…Notably, the severity of depression decreased as the number of household members increased up to a certain threshold. …”
  15. 24695

    Image1_Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods.PNG by Zi-Qian Liang (12650434)

    Published 2022
    “…Finally, DUSP1 may have a targeting relation with paclitaxel and participate in MAPK signaling pathways.…”
  16. 24696

    Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in GRADE: A Randomized Clinical Trial by Jeffrey S. Gonzalez (17468874)

    Published 2024
    “…Research Design and Methods: The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) study of adults with T2DM of < 10 years duration, HbA1c of 6.8-8.5%, and taking metformin monotherapy randomly assigned participants to add insulin glargine U-100, sulfonylurea glimepiride, glucagon-like peptide-1 receptor agonist liraglutide, or dipeptidyl peptidase 4 inhibitor sitagliptin. …”
  17. 24697

    Image3_Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods.TIF by Zi-Qian Liang (12650434)

    Published 2022
    “…Finally, DUSP1 may have a targeting relation with paclitaxel and participate in MAPK signaling pathways.…”
  18. 24698

    Video 1_Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot study.mp4 by Vladimir Gabai (38129)

    Published 2025
    “…Improvement in CBPI was observed after 2–4 weeks of treatment, whereas after 5–6 weeks of the treatment the parameters reached the plateau. After 10 weeks mean PSS score after the treatment decreased from 5.25 to 3.25, PIS score - from 7.0 to 3.27, and number of dogs with excellent and good QoL due to treatment increased from 1 to 12. …”
  19. 24699

    Table_1_Tractography in Type 2 Diabetes Mellitus With Subjective Memory Complaints: A Diffusion Tensor Imaging Study.docx by Jun Wang (5906)

    Published 2022
    “…Decreased axial diffusivity (AD) in the left arcuate was associated with HbA<sub>1c</sub> (r = −0.368, p = 0.049). …”
  20. 24700

    Table1_Intravenous esketamine as an adjuvant for sedation/analgesia outside the operating room: a systematic review and meta-analysis.DOCX by Ziheng Kan (18964144)

    Published 2024
    “…The pooled results of adults showed that compared with drug regimens of the control group, intravenous esketamine combinations were significantly associated with decreased risk of oxygen desaturation (RR = 0.49, 95% CI = [0.34, 0.70]); hypotension (RR = 0.38, 95% CI = [0.31, 0.46]); bradycardia (RR = 0.23, 95% CI = [0.12, 0.43]); injection pain (RR = 0.37, 95% CI = [0.25, 0.53]); body movement (RR = 0.60, 95% CI = [0.41, 0.88]); and propofol consumption (SMD = −1.38, 95% CI = [−2.64, −0.11]), but an increased risk of psychiatric symptoms (RR = 3.10, 95% CI = [2.11, 4.54]) (RR = relative risk; CI = confidence intervals; SMD = standardized mean difference). …”